The France Aminoglycosides Market Size is anticipated to reach USD 142.5 Million by 2035, growing at a CAGR of 4.94% from 2025 to 2035. This is due to the increasing demand for both prescribed and dispensed antibiotics drives market growth. The France aminoglycosides market is concerned with the supply and consumption of aminoglycoside antibiotics within the territory, including the manufacture, distribution, sale, and consumption of the product. Aminoglycosides are generally bactericidal antibiotics that destroy the bacterial cell by inhibiting protein synthesis. Aminoglycosides are mainly used against aerobic gram-negative bacteria.